基因疗法治疗糖尿病的巨大潜力

IF 3.7 3区医学 Q2 CHEMISTRY, MEDICINAL

Chemical Research in Toxicology Pub Date : 2024-08-29 DOI:10.1038/s41574-024-01030-7

Stefan R. Bornstein, J. Fraser Wright, Charlotte Steenblock

引用次数: 0

摘要

基因疗法通过向特定细胞或组织输送外源性治疗核苷酸序列，在治疗各种遗传性和获得性疾病方面前景广阔。最近的研究进展表明，基因疗法可以长期治愈糖尿病，这是目前传统药物疗法无法实现的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The promising potential of gene therapy for diabetes mellitus

Gene therapy holds tremendous promise for treating a wide range of hereditary and acquired diseases by delivering exogenous therapeutic nucleotide sequences into specific cells or tissues. Recent advances support the notion that gene therapy could offer a long-term cure for diabetes mellitus, something that current conventional pharmacotherapies cannot achieve.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chemical Research in Toxicology 医学-毒理学

CiteScore

7.90

自引率

7.30%

发文量

215

审稿时长

3.5 months

期刊介绍： Chemical Research in Toxicology publishes Articles, Rapid Reports, Chemical Profiles, Reviews, Perspectives, Letters to the Editor, and ToxWatch on a wide range of topics in Toxicology that inform a chemical and molecular understanding and capacity to predict biological outcomes on the basis of structures and processes. The overarching goal of activities reported in the Journal are to provide knowledge and innovative approaches needed to promote intelligent solutions for human safety and ecosystem preservation. The journal emphasizes insight concerning mechanisms of toxicity over phenomenological observations. It upholds rigorous chemical, physical and mathematical standards for characterization and application of modern techniques.